Michael Ulz
Stock Analyst at Baird
(1.53)
# 1572
Out of 5,358 analysts
164
Total ratings
49.18%
Success rate
12.83%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
KPTI Karyopharm Therapeut... | Maintains: Outperform | 54 42 | 4.5 | 833.33% | 6 | May 13, 2025 | |
SLN Silence Therapeutics | Maintains: Overweight | 45 25 | 5.44 | 359.56% | 12 | May 9, 2025 | |
VKTX Viking Therapeutics | Maintains: Overweight | 105 102 | 27.82 | 266.64% | 3 | Apr 24, 2025 | |
ALNY Alnylam Pharmaceutic... | Maintains: Equal-Weight | 284 268 | 300.77 | -10.9% | 10 | Apr 11, 2025 | |
KYTX Kyverna Therapeutics | Maintains: Overweight | 40 20 | 3.41 | 486.51% | 2 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 30 22 | 2.48 | 787.1% | 6 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 29 | 11.86 | 144.52% | 1 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 11 7 | 5.25 | 33.33% | 7 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 24 20 | 2.05 | 875.61% | 4 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 20 5 | 5.29 | -5.48% | 5 | Feb 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 18 10 | 1.99 | 402.51% | 2 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 46 96 | 54.27 | 76.89% | 4 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 48 52 | 14.69 | 253.98% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 110 115 | 127.82 | -10.03% | 9 | Jul 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 53 57 | 46.4 | 22.84% | 3 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 36 27 | 16.8 | 60.71% | 4 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 47 65 | n/a | n/a | 4 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 3 7 | 1.6 | 337.5% | 8 | Feb 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 23 12 | n/a | n/a | 4 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 45 48 | 35.3 | 35.98% | 4 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 15 27 | 9.33 | 189.39% | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 37 | n/a | n/a | 9 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 35 40 | n/a | n/a | 4 | May 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 30 20 | 3.8 | 426.32% | 3 | Mar 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 45 | 3.06 | 1370.59% | 1 | Feb 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 20 10 | 0.7 | 1328.57% | 3 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 6 8 | n/a | n/a | 5 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 3 | 2.83 | 6.01% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 18 30 | 5.45 | 450.46% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 135 90 | n/a | n/a | 3 | Aug 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 15 7 | n/a | n/a | 3 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 25 30 | 1.32 | 2172.73% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | n/a | n/a | n/a | 1 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 84 36 | n/a | n/a | 2 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 45 | 10.19 | 341.61% | 1 | Oct 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 500 | n/a | n/a | 1 | Sep 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 12 20 | 0.39 | 5028.21% | 2 | May 28, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 30 | n/a | n/a | 1 | Apr 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 3 1 | n/a | n/a | 4 | Mar 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 4 | n/a | n/a | 3 | Oct 22, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 17 0 | n/a | n/a | 2 | Sep 21, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 680 544 | n/a | n/a | 2 | Jun 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 85 80 | 37.17 | 115.23% | 2 | Nov 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 12 15 | 6.16 | 143.51% | 3 | Jul 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 127 182 | n/a | n/a | 2 | Feb 27, 2017 |